Design Module
The Design Module contains detailed information about the study design, including study type, allocation methods, intervention models, masking information, primary purpose, enrollment details, and biospecimen information. This module provides essential details about how the clinical trial is structured and conducted.
Design Module path is as follows:
Study -> Protocol Section -> Design Module
Design Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT02329132
Study Type:
OBSERVATIONAL
Study:
NCT02329132
Study Brief:
Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
Protocol Section:
NCT02329132
Bio Specs (If Any):
Bio Specs
| Retention | Description | View |
|---|---|---|
| SAMPLES_WITHOUT_DNA | Aqueous humor is obtained at the initial injection of Lucentis. | View |
Design Masking Infos (If Any):
Design Observational Models (If Any):
Design Time Perspectives (If Any):
Design Who Masked (If Any):
Enrollment Infos (If Any):
Enrollment Infos
| Enrollment Type | Enrollment Count | View |
|---|---|---|
| ACTUAL | 30 | View |
Expanded Access Types (If Any):
Phases (If Any):